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Abstract
 
Bruton’s tyrosine kinase (Btk) is a nonreceptor tyrosine kinase involved in precursor B (pre-B)
 
cell receptor signaling. Here we demonstrate that Btk-deficient mice have an 
 
z
 
50% reduction
 
in the frequency of immunoglobulin (Ig) 
 
l
 
 light chain expression, already at the immature B
cell stage in the bone marrow. Conversely, transgenic mice expressing the activated mutant
 
Btk
 
E41K
 
 showed increased 
 
l
 
 usage. As the 
 
k
 
/
 
l
 
 ratio is dependent on (a) the level and kinetics of
 
k
 
 and 
 
l
 
 locus activation, (b) the life span of pre-B cells, and (c) the extent of receptor editing,
we analyzed the role of Btk in these processes. Enforced expression of the Bcl-2 apoptosis in-
hibitor did not alter the Btk dependence of 
 
l
 
 usage. Crossing 3-83
 
md
 
 autoantibody transgenic
mice into Btk-deficient mice showed that Btk is not essential for receptor editing. Also, Btk-
 
deficient surface Ig
 
1
 
 B cells that were generated in vitro in interleukin 7-driven bone marrow
cultures manifested reduced 
 
l
 
 usage. An intrinsic defect in 
 
l
 
 locus recombination was further
supported by the finding in Btk-deficient mice of reduced 
 
l
 
 usage in the fraction of pre-B cells
that express light chains in their cytoplasm. These results implicate Btk in the regulation of the
activation of the 
 
l
 
 locus for V(D)J recombination in pre-B cells.
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Introduction
 
During early B cell development in the bone marrow, Ig H
and L chain variable region genes are assembled from com-
ponent V, (D), and J gene segments (for reviews, see refer-
ences 1–3). V(D)J recombination is a highly ordered pro-
cess, initiated by DNA rearrangements at the H chain in
pro-B cells. The expression of a functional 
 
m
 
 H chain is
monitored through the formation of a (pre-) B cell recep-
tor (BCR)
 
1
 
 complex, together with 
 
l
 
5 and V
 
pre-B 
 
proteins.
Signaling through the pre-BCR results in feedback inhibi-
tion of H chain VDJ recombination to ensure allelic exclu-
sion and IL-7–dependent proliferative expansion. The rap-
idly proliferating pre-B cells then exit the cell cycle and
perform Ig L chain rearrangements, leading to the deposi-
tion of complete Ig molecules on the cell surface (2, 3).
The murine 
 
k
 
 L chain locus contains 70–90 functional V
 
k
 
gene segments, present in both orientations relative to the
four functional J
 
k
 
 elements. By contrast, the 
 
l
 
 locus in the
mouse is very small; it consists of only three functional V
 
l
 
and three functional J
 
l
 
 
 
segments. Ig 
 
k
 
 and 
 
l
 
 L chain rear-
rangements occur independently and at different kinetics,
with sequential activation of the 
 
k
 
 and 
 
l
 
 loci (4–6). The
privileged activation of the 
 
k
 
 locus is thought to determine
the final ratio of 
 
k
 
1
 
 to 
 
l
 
1
 
 mature B cells of 95:5 in wild-
type (WT) mice.
 
PCR analyses of the Ig 
 
k
 
 L chain locus in single develop-
ing B cells in the bone marrow have demonstrated the pres-
ence of multiple in- and out-of-frame rearrangements in
small pre-B cells (6). These findings indicated that the BCR
does not signal allelic or isotypic exclusion of the Ig 
 
k
 
 or 
 
l
 
L chain loci, allowing secondary L chain rearrangements to
occur. Cells with a first productive rearrangement on one
allele are rapidly selected to enter the immature B cell com-
partment (6). The rearrangement machinery remains active
in immature B cells and is only turned off at the transition
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to mature B cells (7–9). If an immature B cell expresses an
Ig that has reactivity with an autoantigen in the bone mar-
row, continued Ig L chain rearrangement can be induced to
rescue autoreactive B cells from tolerance elimination, a
phenomenon called receptor editing (10–12).
One of the molecules that is involved in pre-BCR sig-
naling and thereby directs B cell development is the Tec
family nonreceptor Bruton’s tyrosine kinase (Btk; for a re-
view, see reference 13). Upon BCR stimulation, Btk phos-
phorylation and kinase activity are increased (14–16) prob-
ably by the activity of Src family kinases (13, 17).
Concomitantly, Btk is targeted to the plasma membrane by
the binding of its pleckstrin homology (PH) domain to the
second messenger phospatidylinositol-(3,4,5)triphosphate
(18). Binding of Btk to the linker protein BLNK/SLP-65 is
crucial for phosphorylation and activation of phospholipase
C
 
g
 
2 by Btk, implicating Btk as a mediator of BCR-
induced Ca
 
2
 
1
 
 mobilization (19).
Mutations in Btk lead to X-linked agammaglobulinemia
(XLA) in humans and X-linked immunodeficiency (
 
xid
 
) in
mice (for reviews, see references 20–23). XLA is character-
ized by an almost complete arrest of B cell development at
the pre-B cell level (24, 25). As a result, XLA patients have
profoundly reduced numbers of B cells in the peripheral
blood, and serum Ig levels of all classes are very low (24).
Btk-deficient mice display a milder phenotype, mainly re-
flecting poor survival of peripheral B cells. B cell numbers in
the spleen and lymph nodes are reduced by 50%, and IgM
and IgG3 levels in the serum are low (20, 26). Nevertheless,
mouse Btk-deficient cells also showed an impaired transi-
tion from pre-B to immature B cells by analysis of competi-
tion in vivo between Btk
 
1
 
 and Btk
 
2
 
 cells in females het-
erozygous for a targeted mutation in the Btk gene (27).
Both in XLA patients and in 
 
xid
 
 mice the absence of Btk
appeared to result in a decrease of Ig 
 
l
 
 L chain usage in pe-
ripheral B cells (24, 28, 29). The reduced frequency of Ig 
 
l
 
L chain–expressing cells could either reflect an intrinsic fea-
ture of the L chain rearrangement process in the absence of
Btk signaling or could alternatively be secondary to an al-
tered antigen-dependent peripheral repertoire selection in
Btk-deficient mice. To distinguish between these two pos-
sibilities, we determined the proportions of Ig 
 
l
 
1
 
 B cells
during B cell differentiation in Btk-deficient mice, as well
as in transgenic mice that express a constitutively activated
form of Btk, the E41K PH domain mutant (27, 30). As the
 
k
 
 to 
 
l
 
 ratio is dependent on (a) the level and kinetics of the
activation of the 
 
k
 
 and 
 
l
 
 loci for recombination, (b) the life
span of pre-B cells that are in the process of L chain rear-
rangement, and (c) the extent of receptor editing of autore-
active B cells, we analyzed the involvement of Btk in these
processes in detail.
 
Materials and Methods
 
Mice. Btk
 
2
 
/lacZ
 
 mice (27) were crossed on a C57BL/6 back-
ground for over five generations. CD19-h
 
Btk
 
WT
 
 and CD19-
h
 
Btk
 
E41K
 
 transgenic mice that express WT and E41K-mutated
human Btk (hBtk), respectively, under the control of the CD19
 
promoter region have been described previously (30) and were
on a mixed background containing 129/Sv, C57BL/6, and FVB.
For the generation of 
 
l
 
5-h
 
Btk
 
E41K
 
 mice we used a 1.5-kb NotI-
BglII fragment containing the murine 
 
l
 
5 promoter and a 6.5-kb
ClaI-NotI fragment with the 3
 
9
 
 locus control region of the 
 
l
 
5-
V
 
pre-B1 
 
locus (31). The promoter and locus control region were
cloned into the unique SwaI and SmaI sites, respectively, present
in the cosmid vector pTL5 containing a BglII-NotI-XhoI-SwaI-
PvuI-KpnI-SmaI-NotI-BglII polylinker (32). Next, an 
 
z
 
27-kb
PvuI-NotI fragment containing the E41K-mutated h
 
Btk
 
 cDNA/
genomic DNA fragment (32) was cloned into the 
 
l
 
5/pTL5 vec-
tor, using the PvuI and KpnI sites in the polylinker. The 
 
z
 
35-kb
NotI insert of the 
 
l
 
5-h
 
Btk
 
E41K
 
 construct was excised from the
vector and purified, using standard methods. DNA (
 
z
 
2–4 ng/
 
m
 
l)
was injected into the pronuclei of FVB fertilized oocytes, which
were subsequently implanted into pseudopregnant foster mice.
Founder mice were crossed with 
 
Btk
 
2
 
/lacZ
 
 mice. E
 
m
 
-2-22 Bcl-2
 
transgenic mice (33) and 3-83
 
md
 
 mice (10) were on a C57BL/6
and a B10.D2 background, respectively. All mice were bred and
maintained in the animal care facility at the Erasmus University
Rotterdam.
 
Mouse Genotyping. 
 
To determine the 
 
Btk
 
 genotype and
score the presence of the CD19-h
 
Btk
 
WT
 
 or CD19-h
 
Btk
 
E41K
 
 trans-
genes, tail DNA was analyzed by Southern blot analysis of
BamHI digests, as described previously (27, 30). The presence of
the E
 
m
 
-2-22 Bcl-2
 
 transgene was evaluated by PCR, using prim-
ers that are specific for the SV40 DNA sequences flanking the
Bcl-2 transgene: 5
 
9
 
-GGCACTATACATCAAATATTC-3
 
9
 
 and
5
 
9
 
-TGAAGGAACCTTACTTCTGT-3
 
9
 
. The presence of the
3-83
 
md
 
 transgene was identified by Southern blot analysis of
BamHI or EcoRI digests, using a J
 
k
 
-specific probe as described
previously (34).
 
Flow Cytometric Analyses.
 
Preparation of single cell suspen-
sions, flow cytometry, and determination of 
 
b
 
-galactosidase ac-
tivity by loading cells with fluorescein-di-
 
b
 
-galactopyranoside
substrate have been described previously (27, 32). Events (5 
 
3
 
10
 
4
 
–5 
 
3
 
 10
 
5
 
) were scored using a FACSCalibur™ flow cytome-
ter and analyzed by CELLQuest™ software (Becton Dickinson).
The following mAbs were obtained from BD PharMingen:
FITC-conjugated anti-B220–RA3-6B2, anti-
 
k
 
–R5-240, and
anti-IgM, PE-conjugated anti-CD19, anti-CD43, and anti-H2–
K
 
d
 
; and CyChrome-conjugated anti-B220–RA3-6B2 and bio-
tinylated anti-CD19, anti-
 
l
 
1
 
 and 
 
l
 
2
 
–R26-46, anti–IgM, and
anti-H2–Kb. PE-conjugated anti-IgD was from Southern Bio-
technology Associates, Inc. The anti–3-83 clonotype 54.1 anti-
body has been described previously (35). Secondary antibodies
were PE-conjugated goat anti–rat, Tri-color, or allophycocyanin-
conjugated Streptavidin, purchased from Caltag. Affinity-purified
polyclonal rabbit anti-Btk (BD PharMingen) was used for intra-
cellular flow cytometric detection of cytoplasmic Btk protein us-
ing FITC-conjugated goat anti–rabbit total Ig (Nordic) as a sec-
ondary antibody (32).
IL-7–driven Bone Marrow Cultures. Primary pre-B cell cul-
tures were performed as described previously (36). In brief, bone
marrow cells were depleted of erythrocytes by standard ammo-
nium-chloride lysis, and subsequently IgM2 B cells were purified
by negative selection. Cell suspensions were labeled with biotiny-
lated anti-IgM (BD PharMingen) and incubated with Streptavi-
din-coated microbeads (Miltenyi Biotec). After cell separation us-
ing MACS column purification, the IgM2 fraction was collected
and purity was confirmed by flow cytometry. Cells were cultured
in IMDM  medium, supplemented with 10% heat-inactivated
FCS at 2 3 106 cells/well in 24-well plates at 378C in the pres-1171 Dingjan et al.
ence of 100 U/ml of recombinant murine IL-7 (R&D Systems).
After 5 d of culture, cells were washed and recultured on S17
stromal cells with or without 100 U/ml IL-7 for 48 h.
Results
Reduced Ig l L Chain Usage throughout B Cell Development
in Btk-deficient Mice. The expression of Ig l L chain was
investigated in Btk-deficient mice, in which the Btk gene is
inactivated by a targeted insertion of a lacZ reporter (27).
Total splenic cell suspensions were analyzed by three-color
flow cytometry, using an antibody specific for the Ig l1 and
l2 L chain constant regions in conjunction with anti-B220
and anti-CD19. The proportions of B cells that expressed Ig
l L chain on the cell surface were 4.9% 6 0.2 (n = 7) and
5.0 6 0.2 (n = 6) in the spleen of Btk1 and Btk1/2 control
mice, respectively. By contrast, we observed a significant re-
duction of this proportion in Btk2 mice (2.3 6 0.4; n = 10).
Next, l expression was determined in individual B cell
subpopulations in bone marrow and spleen. We performed
four-color flow cytometry experiments, using anti-l L
chain antibodies in combination with mAbs specific for the
B220, IgM, and IgD surface markers, which define succes-
sive stages of B cell development (Fig. 1). In Btk1 mice,
10–16% of cells within the immature B cell subpopulations,
including immature IgM1IgD2 and transitional IgM1
IgDlow B cells in the bone marrow and immature IgMhigh
IgDlow B cells in the spleen, were found to express Ig l L
chain. By contrast, in the Btk2 mice only 5–7% of cells
within these subpopulations were l1, i.e., about half the
number found in WT mice. In the mature B cell subpopu-
lations, including the IgM1IgDhigh cells in bone marrow
and spleen, Ig l L chain was expressed in 4–5% of cells in
Btk1 mice and in 2.5–3.5% of cells in Btk2 mice. Finally,
we found that in the subpopulation of large lymphoblastoid
cells in the spleen of Btk1 and Btk2 mice 8–12% and 4–6%
were  l1, respectively (Fig. 1). In Btk1/2 heterozygous
mice, intermediate values of l1 cells were found in the
bone marrow immature cells (data not shown).
These findings demonstrate that the absence of Btk leads
to a significantly reduced frequency of l usage, already
from the immature B cell stage onwards.
Reduced l L Chain Usage Is an Intrinsic Feature of Btk-defi-
cient B Cells. Although we demonstrated that Ig L chain
isotype usage is determined in the bone marrow, the possi-
bility remained that the reduced l usage did not reflect an
intrinsic feature of Btk-deficient B cells. Alternatively, this
phenomenon could originate from the xid immune status of
the Btk-deficient mice, which may, directly or indirectly,
affect selection events at the pre-B to B cell progression.
Figure 1. Ig l L chain expression
during B cell development in Btk1
and Btk2 mice. Bone marrow and
spleen single cell suspensions were
stained with mAbs specific for
B220, IgM, IgD, and Ig l. Spleen
lymphoblasts were gated based on
large forward scatter values. The in-
dicated B cell subpopulations were
gated (top) and analyzed for B220
and Ig l L chain expression (bot-
tom). On the basis of IgM and IgD
expression, B cell subpopulations
were defined in the bone marrow:
E, IgM1IgD2 immature B cells; ET,
IgM1IgDlow transitional immature B cells; F, IgM1IgD1 mature recirculating B cells (reference 47). In the spleen: I, mature IgMlow
IgDhigh; II, IgMhighIgDhigh; III, immature IgMhighIgDlow B cells. Data are displayed as dot plots, and the percentages of l1 cells of the
B2201 B cell population are indicated. Data shown are representative of 10 Btk1 and 8 Btk2 mice animals examined. 1172 Btk Regulates Immunoglobulin l Light Chain Rearrangements
To address this issue, we analyzed heterozygous Btk1/2
female mice, which do not manifest the xid phenotype due
to the selective advantage of B cells that have the intact
Btk1 allele on their active X chromosome (27). Because of
the process of random X chromosome inactivation, z50%
of the B cell progenitors have the disrupted Btk2/lacZ1 al-
lele on the active X chromosome. When cells reach a dif-
ferentiation stage at which Btk is required, their further de-
velopment is hampered. As a consequence of this selective
disadvantage, the proportions of Btk2/lacZ1 cells decrease
below the value of 50%, finally to undetectable levels in the
mature peripheral B cells (27).
We analyzed splenic cell samples from Btk1/2 heterozy-
gous females for l usage in four-color flow cytometry ex-
periments, using fluorescein-di-b-galactopyranoside as a
fluorogenic substrate in conjunction with surface labeling
to define the immature IgDlowB2201 B cell subpopulation
in the spleen. In this fraction, z30% of the cells expressed
lacZ, enabling a separate analysis of the Btk1/lacZ2 and
Btk2/lacZ1 B cell populations. We found that the propor-
tion of Ig l1 cells within the Btk2 immature IgDlowB2201
subpopulation was reduced to 3.6% 6 0.7, when compared
with Btk1 immature B cells (6.3% 6 0.9; Fig. 2).
These results show that reduced l usage is an intrinsic
feature of Btk-deficient B cells, which is independent of
the xid immune status of the mice.
Bcl-2 Overexpression Does Not Alter the Btk Dependence of
Ig L Chain Isotype Usage. The finding of reduced l  ex-
pression in Btk-deficient cells may be explained by a role
for Btk signal transduction in extending the life span of
pre-B cells that are in the process of L chain rearrangement.
Enforced expression of the antiapoptotic Bcl-2 gene results
in elevated Ig l expression in mature B cells (37). As the Ig
k and l loci are sequentially activated for VL-JL recombina-
tion, Bcl-2 gene is assumed to provide an extended time
window per cell for Ig L chain rearrangement (37). To in-
vestigate a role for Btk in pre-B cell survival, we have
crossed Btk2/lacZ mice onto an Em-Bcl-2 transgenic back-
ground (33). We investigated l usage in Em-Bcl-2 trans-
genic Btk1/2 female mice, in which the Btk1 and Btk2 im-
mature splenic IgDlowB2201 B cell population can be
analyzed within a single animal. In these mice the Btk1
subpopulation had a significantly higher percentage (12.8% 6
1.3; n = 4) of l1 B cells, compared with the Btk2 subpop-
ulation (7.3% 6 1.5; Fig. 2).
These analyses demonstrate that even if the life span of
pre-B cells is extended by the presence of the Bcl-2 trans-
gene, the Btk-deficient B cell population still manifests an
z50% reduction in l usage. Therefore, we conclude that
protection of pre-B cells from apoptosis does not alter the
Btk dependence of the frequency of l usage.
Expression of a Constitutively Activated Btk Mutant Increases
l Usage. To further test the involvement of Btk signaling
in the mechanism that sets the k to l isotype ratio in vivo,
we examined mice that express the constitutively activated
BtkE41K mutant. This Glu-to-Lys PH domain Btk mutant
shows increased membrane localization in quiescent cells,
independent of phosphatidylinositol 3-kinase activity (38,
39). In CD19-hBtkE41K transgenic mice, which express
BtkE41K under the control of the CD19 promoter region, B
cell development is almost completely arrested at the im-
mature B cell stage in the bone marrow, probably because
the BtkE41K mutant mimics BCR occupancy by autoanti-
gens (30; Fig. 3).
In four-color flow cytometry experiments using anti-
bodies to B220, IgM, IgD, and Ig l, the CD19-hBtkE41K
transgenic mice manifested a significant increase in the fre-
quency of l usage (z11% in the IgM1IgD2/low immature
B cell fraction in the bone marrow compared with z6% in
nontransgenic littermates; Fig. 3). This increase was specifi-
cally associated with the expression of the BtkE41K muta-
tion, as the control CD19-hBtkWT transgenic mice in
which the CD19 promoter drives expression of WT hBtk
contained normal proportions of l1 B cells (Fig. 3). We
conclude that the presence of constitutively activated Btk
enhances l usage.
Ig l Usage in CD19-hBtkE41K Em-Bcl-2 Double Transgenic
Mice. To confirm that Btk-mediated signaling increases l
usage, independent of the life span of pre-B cells, we
crossed CD19-hBtkE41K and CD19-hBtkWT transgenic mice
onto the Em-Bcl-2 background. The enforced expression of
Bcl-2 partially prevented central deletion of B cells in
CD19-hBtkE41K transgenic mice, as was evident from the
presence of substantial numbers of mature B cells in bone
marrow and spleen of CD19-hBtkE41K E m-Bcl-2 double
transgenic mice (Fig. 3). We analyzed Ig l L chain expres-
Figure 2. Separate effects of Btk and Bcl-2 on Ig l L
chain usage. Four-color flow cytometric analyses of spleen
cells of the indicated mice. The immature IgDlowB2201
compartment was gated (top) and analyzed for lacZ and l
L chain expression (bottom). The percentages of l1 cells
within the indicated lacZ1 or lacZ2 subpopulations are
given. Data are shown as dot plots representative of the
4–10 mice examined.1173 Dingjan et al.
sion in the B cell populations in bone marrow and spleen
from Em-Bcl-2 transgenic, CD19-hBtkE41K E m-Bcl-2, and
CD19-hBtkWT E m-Bcl-2 double transgenic mice (Fig. 3).
Consistent with previous reports (37), Em-Bcl-2 mice or
CD19-hBtkWT Em-Bcl-2 double transgenic mice had signifi-
cantly higher percentages of l1 cells in the immature
IgM1IgD2/low B cell population in the bone marrow
(z24%), when compared with nontransgenic or CD19-
hBtkWT littermates (z7%). Most importantly, in CD19-
hBtkE41K Em-Bcl-2 double transgenic mice we found even
higher proportions of Ig l1 cells (z35–40%). Similar sig-
nificant differences were found in the mature recirculating
IgM1IgD1 B cell population in the bone marrow and in
the spleen (data not shown, and Fig. 3). Therefore, we
conclude that the BtkE41K-mediated increase of l usage
cannot be explained by an effect of this mutant on pre-B
cell survival.
Btk Signaling Is Not Essential for Receptor Editing. As re-
ceptor editing may occur frequently during normal B cell
development and is accompanied by increased l usage (10,
12, 40), we tested whether the reduced l expression in
Btk-deficient B cells results from the inability of these cells
to perform receptor editing. Therefore, Btk-deficient mice
were crossed with 3-83md transgenic mice bearing rear-
ranged H and L chain genes encoding an antibody that spe-
cifically recognizes MHC class I H-2Kk,b (10). On a non-
deleting H-2Kd background, the 3-83md mice contain a
virtually monoclonal B cell population bearing the 3-83md
BCR, as identified by the antiidiotypic antibody 54.1 (Fig.
4). In contrast, centrally deleting 3-83md/H2-Kb mice ex-
hibit the phenotype of central B cell tolerance in which id-
iotype-positive B cells are present in the bone marrow (Fig.
4 A), but are efficiently deleted from the spleen and lymph
nodes (10). Only small numbers of B cells are present in the
spleen and lymph nodes and most of these lack the autore-
active specificity (.94% and .99%, respectively; Fig. 4, B
and C). These B cells, which have performed receptor ed-
iting, express the transgenic H chain together with endoge-
nous L chain, a large fraction (z50%) of which is l (10;
Fig. 4, B and C). Btk-deficient 3-83md/H2-Kb mice mani-
fested similar B cell numbers in the spleen and lymph
nodes, when compared with Btk1 littermates. Deletion of
autoreactive 3-83md–expressing B cells occurred in the ab-
sence of Btk, but was less efficient in the spleen than in
lymph nodes (z70 and z97% of B cells were 54.12, re-
spectively; Fig. 4, B and C). In the Btk-deficient 3-83md/
H2-Kb mice, significant numbers of idiotype-negative B
cells were present, 25–40% of which expressed Ig l L
chain. Therefore, we conclude that receptor editing can
occur in Btk-deficient autoreactive immature B cells.
Figure 3. Increased l usage in CD19-hBtkE41K mice independent of cell survival. Four-color flow cytometric analyses of bone marrow and spleen of
the indicated mice. Single cell suspensions were stained with mAbs specific for B220, IgM, IgD, and Ig l. On the basis of IgM and IgD expression, the
immature IgM1IgD2/low B cell population in the bone marrow (top, fraction E1ET; see legend to Fig. 1) and the total IgM1IgD1 B cell population in
the spleen (bottom) were gated and analyzed for l usage. Data shown are representative of five to nine mice examined per group. At the bottom, the total
splenic B cell numbers of the indicated animals are given as mean values 6 SD (determined by flow cytometric analysis using mAbs to B220 and CD19).1174 Btk Regulates Immunoglobulin l Light Chain Rearrangements
Reduced l Usage in Btk-deficient B Cells Generated in Bone
Marrow Cultures In Vitro. To further investigate the rela-
tion between Btk signaling and l chain rearrangement, we
performed IL-7–driven bone marrow culture experiments
as described previously (7, 41). When surface IgM2 bone
marrow cell suspensions from WT or Btk-deficient mice
were cultured for 5 d in the presence of IL-7, the majority
of cells consisted of B2201IgM2 pre-B cells that expressed
m H chain in their cytoplasm. In these cultures, a consider-
able fraction of the WT B2201 cells (z15%) matured to
surface IgM1 B cells, while ,5% of Btk-deficient B2201
cells were surface IgM1, suggesting that the progression
from pre-B cell to sIg1 B cell is hampered in Btk-deficient
mice. When cells were subsequently cultured without IL-7
on S17 stroma cells for 48 h, allowing the cells to exit from
the cell cycle and further differentiate (36), significant frac-
tions of the WT (z40%) and Btk-deficient (z30%) B2201
cells were surface IgM1. In these cultures, in vitro–gener-
ated Btk-deficient surface IgM1 B cells showed signifi-
cantly reduced usage of l L chains, compared with WT B
cells (Fig. 5 A).
Reduced Cytoplasmic L Chain Expression in Btk-deficient
Pre-B Cells. About one fifth of all pre-B cells have been
reported to express m H chain and L chains in their cyto-
plasm without depositing IgM molecules on their surface
(3). In the bone marrow of Btk1 and Btk2 mice, we deter-
mined the proportions of sIgM2 cells that express k and l
L chain in their cytoplasm. In four-color flow cytometry
experiments, intracellular staining for H or L chain expres-
sion was combined with surface labeling to define the
IgM2IgD2B2201 pre-B cells. In Btk1 and Btk2 mice, the
proportions of sIgM2 B cells that expressed cytoplasmic m
H chain were similar. By contrast, the percentage of sIgM2
B cells that were positive for k or l L chains in their cyto-
plasm was significantly reduced in Btk-deficient mice,
compared with WT mice (Fig. 5 B). The absence of Btk
had a much stronger effect on l expression, resulting in de-
creased frequencies of l usage in Btk-deficient sIgM2 cells
(1.9 compared with 5.8% in WT mice).
Transient Expression of BtkE41K in Pre-B Cells Increases l
Usage. To confirm that the BtkE41K mutant exerts its role
on l L chain usage at the pre-B cell stage, we generated
Figure 4. Analysis of receptor editing in 3-83md
transgenic Btk1 and Btk2 mice. Single cell suspen-
sions were stained with mAbs specific for B220,
IgM, Ig l, as well as the clonotype-specific rat mAb
54.1 that detects idiotype-positive B cells in 3-83md
transgenic mice. The Btk dependence of receptor
editing was analyzed in Btk1 and Btk2 centrally de-
leting 3-83md transgenic mice on an H-2Kd/H-2Kb
F1 background. As controls, nondeleting 3-83md
transgenic mice (H-2Kd) and nontransgenic (H-
2Kb) Btk1 mice are shown. (A) Presence of 54.11 B
cells in the bone marrow of the indicated mice. In
the spleen (B) and mesenteric lymph node (C), the
B cell population was gated (numbers indicate the
percentages of B2201IgM1 cells from total lym-
phoid cells) and analyzed for the expression of l and
the 54.1 idiotype. The numbers in the quadrants in-
dicate the percentages of B2201IgM1 cells that are
l154.12, l154.11, and l254.11. Data shown are
representative of the mice examined.1175 Dingjan et al.
transgenic mice in which BtkE41K expression was driven by
the l5 promoter and the 39 l5-Vpre-B1 locus control region.
As shown in Fig. 6 A, the transgene was selectively ex-
pressed in early CD431B2201 B cell precursors. In contrast
to the CD19-hBtkE41K transgenic mice, the l5-hBtkE41K
mice did not manifest an arrest of B cell development, as the
sizes of the B cell subpopulations in bone marrow and pe-
ripheral organs were in the normal ranges (Fig. 6, and data
not shown). When l5-hBtkE41K transgenic and nontrans-
genic mice on a Btk2 background were compared, expres-
sion of the transgene was found to increase l usage. The
frequencies of l1 cells in the IgM1IgD2/low immature B cell
population were 4.9 6 0.3 in Btk2 mice (n = 4) and 8.9 6
0.7 in l5-hBtkE41K transgenic Btk2 mice (n = 4; Fig. 6 B).
This finding showed that transient expression of BtkE41K in
CD431 pro- and pre-B cells increased the frequency of l
usage.
Discussion
In this report we show that the absence of Btk during
murine B cell development results in a 50% reduction of
the proportion of Ig l L chain–expressing cells. Con-
versely, expression of the constitutively activated BtkE41K
mutant significantly promotes l usage. The observed l ex-
pression profiles of Btk-deficient, CD19hBtkE41K, and
l5-hBtkE41K mice during B cell development show that the
effect of Btk signaling is at the level of the Ig L chain rear-
rangement events in pre-B cells, and not a result of anti-
gen-dependent selection processes in the periphery.
Moreover, the comparison of Btk1 and Btk2 B cells in the
spleen of heterozygous females shows that reduced l usage
is an intrinsic feature of Btk-deficient B cells and not asso-
ciated with the immunodeficient status of Btk-deficient
mice. We conclude that the regulation of Vl-Jl recombina-
tion events in the bone marrow is partially dependent on
Btk signal transduction.
It has been shown that the k to l ratio of 95:5 in murine
cells reflects a developmental hit-and-run program of B
cells in which k gene rearrangements precede l rearrange-
ments, whereby l usage is also dependent on the pre-B cell
life span and the extent of receptor editing in immature B
cells (4–6, 37).
The finding of increased l L chain usage in Bcl-2 trans-
genic animals indicates that the extent of secondary rear-
rangement events in pre-B cells with a nonfunctional L
chain rearrangement is dependent on their life span (37).
Although Btk is involved in the survival of mature periph-
eral B cells (20, 42), a role for Btk in the survival of pre-B
cells in the mouse is not very likely. The absolute numbers
of pre-B cells that are generated in the bone marrow of
Btk-deficient mice are normal, and Btk-deficient B cell
precursors in the bone marrow have the same kinetics of
turnover (20, 26, 27, 43). Moreover, our analyses in Btk-
Figure 5. Decreased l L chain usage in in vitro–generated Btk2 B cells
and in Btk2 pre-B cells in vivo. (A) Fraction of B2201 cells that express k
and l L chain on the cell surface in bone marrow cultures from Btk1 and
Btk2 mice (n = 10). Cells were grown in IL-7 for 5 d and subsequently
recultured on S17 stroma in the absence of IL-7 for 48 h. Cells were
stained with mAbs specific for B220, IgM, IgD, and either k or l. (B)
Fraction of sIgM2sIgD2B2201 cells that express L chains in their cyto-
plasm in the bone marrow of Btk1 and Btk2 mice (n = 8).
Figure 6. Increase of l usage by transient BtkE41K expression in l5-
hBtkE41K mice. (A) Intracellular Btk expression in B cells from l5-hBtkE41K
transgenic mice on a Btk2 background. Btk expression profiles are dis-
played as histograms for CD431B2201IgM2 pro-B cells, CD432
B2201IgM2 pre-B cells, and B2201IgM1IgD2 immature B cells of
l5-hBtkE41K transgenic mice (black lines), together with those of Btk2
mice, which served as background stainings (thin lines). (B) Four-color
flow cytometric analyses of bone marrow of the indicated mice. On the ba-
sis of IgM and IgD expression (top), the immature IgM1IgD2/low B cell
population (fraction E1ET; see legend to Fig. 1) and the IgM1IgD1 recir-
culating B cell population (fraction F) were gated and analyzed for B220
and l usage (bottom). Data shown are representative of the mice examined.1176 Btk Regulates Immunoglobulin l Light Chain Rearrangements
deficient and BtkE41K mice on an Em-Bcl-2 transgenic back-
ground show that protection of pre-B cells from apoptosis
by the expression of the Bcl-2 transgene did not alter the
Btk dependence of the frequency of l usage (Figs. 2 and 3).
Therefore we conclude that the influence of Btk on l us-
age is not at the level of the regulation of the time window
for Ig L chain rearrangements in pre-B cells.
As our findings argue against a role of Btk in pre-B cell
survival, the relationship between Btk activity and l usage
would point at a role for Btk either in the regulation of the
initiation of gene rearrangement at the l L chain locus or in
the induction of receptor editing. As comparable numbers
of 54.1 idiotype-negative B cells were present in Btk1 and
Btk2 centrally deleting 3-83md autoantibody transgenic
mice, we conclude that Btk signaling is not essential for re-
ceptor editing. Nevertheless, a 50% reduction of l usage
was found in the spleen and lymph nodes of Btk-deficient
3-83md transgenic mice (Fig. 4). This finding may indicate
that in Btk-deficient mice the mechanism of receptor edit-
ing is intact, but l usage is decreased due to impaired initia-
tion of l L chain rearrangement, or alternatively that the
overall level of Ig L chain replacement is reduced. Recent
experiments indicated that receptor editing represents a ma-
jor force in shaping the antibody repertoire in the mouse, as
it was found that z25% of all Ig L chains are produced by
gene replacement (12). Whether all of these replacements
are induced by self-reactive or nonpairing receptors is cur-
rently unknown. Thus, it is possible that the 15–20% of all
small pre-B cells that have been reported to express Ig L
chains in their cytoplasm (44) may have deposited IgM on
the membrane, but sIgM expression has subsequently been
downregulated due to binding of an autoantigen. Such cells
would only be present in the bone marrow for a very short
time, as receptor editing has been estimated to take only 2 h
(12). In this model, the reduced cytoplasmic l L chain ex-
pression observed in Btk-deficient pre-B cells may reflect
reduced receptor editing in the absence of Btk signaling.
Alternatively, the pre-B cells that express m H chain and
L chains in their cytoplasm, but not on their surface, may
produce Ig L chains that are not capable of pairing with the
m H chain in that cell (6). On the basis of these findings, it
could be assumed that the k to l ratio in cytoplasmic L
chain–positive pre-B cells reflects the intrinsic probabilities
for productive rearrangements on the k and l loci. In this
alternative model, the observed significant reduction of the
frequencies of cytoplasmic l L chain expressing pre-B cells
would point at an intrinsic defect in l gene rearrangement
in Btk-deficient cells. Such a role for Btk in the initiation
of l gene rearrangement would, together with the obser-
vation of hampered in vitro progression of Btk-deficient
pre-B cells into surface IgM1 B cells in IL-7–driven bone
marrow cultures, implicate Btk in pre-BCR signaling in
the mouse. In this context, impaired L chain rearrange-
ment of Btk-deficient cells would be consistent with their
selective disadvantage at the transition from small pre-B to
immature B cell, as we previously observed in an in vivo
competition assay (27). Obviously, in this model Btk sig-
naling could mediate developmental progression to a stage
of B cell development in which l L chain rearrangements
are initiated, or alternatively Btk signaling could directly
control the rate or efficiency of L chain rearrangement.
The observed increase in coding and signal broken DNA
ends at multiple gene segments in the Ig k locus across the
pro-B to pre-B cell transition supported the hypothesis
that the role of pre-BCR signaling is not limited to ex-
panding the population undergoing L chain gene rear-
rangement, but actually increases the activity of V(D)J re-
combination at the Ig k locus (45). During the rounds of
DNA replication that follow pre-BCR expression, pre-
BCR signaling could then, e.g., induce alterations of the
chromatin structure of the L chain loci to provide accessi-
bility to the V(D)J recombinase system (1, 46). As Btk does
not appear to influence the size of the pre-B cell popula-
tion or its kinetics of turnover in the mouse (20, 26, 27,
43), we would propose that Btk is most likely involved in
the activation of the L chain loci, in particular the l locus,
for recombination. In this context, the differential effect of
Btk signaling on the k and l loci would reflect a different
regulation of the activation of the two loci for recombina-
tion. This is to be expected, as the loci become accessible
for recombination at different stages of B cell develop-
ment, i.e., large cycling pre-B cells for the k locus and
small quiescent pre-B cells for the l locus (5).
A role for Btk in the initiation of l L chain rearrange-
ment rather than receptor editing would be supported by
the finding of increased Ig l usage, when the constitutively
activated BtkE41K mutant was selectively expressed in early
CD431 pro- and large pre-B cells, but not in CD432 small
pre-B cells (Fig. 6). Normally, both the initiation of l L
chain rearrangement and receptor editing take place at the
small pre-B cell stage (5, 12) where the BtkE41K mutant is
no longer expressed in the l5-hBtkE41K mice. Therefore,
the increased Ig l usage in l5-hBtkE41K mice may reflect
premature initiation of Vl-Jl recombination. However, as
our findings do not provide direct evidence for the pres-
ence of a Btk-mediated signaling pathway controlling the
initiation of L chain rearrangements, further experiments
are required to directly demonstrate whether Btk signaling
activates the l locus for recombination, e.g., by changing
its accessibility for the V(D)J recombinase.
In summary, the observed correlation between Btk ac-
tivity and the frequency of l usage indicates a role for Btk-
mediated signaling in the activation of Ig l L chain locus
for V(D)J recombination. As a result, Btk signaling contrib-
utes significantly to the mechanism that sets the k/l isotype
ratio in the mouse. Although we have shown that Btk is
not essential for receptor editing in the 3-83md autoreac-
tive model, it remains possible that the absence of Btk
signaling results in a decrease in the extent of L chain re-
placement events, and thereby in decreased l usage in Btk-
deficient B cells. Alternatively, Btk could be involved in
the activation of the l L chain locus for recombination. A
role for Btk in the initiation of L chain rearrangements may
also explain the developmental arrest in those XLA patients
with normal pre-B cell numbers that nevertheless show im-
paired maturation to surface Ig1 B cells (23).1177 Dingjan et al.
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